Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (CSE: $CURA.C) (CSE: $TTT.C) (TSX: $WEED.CA) (NYSE: $CGC) (TSXV: $KHRN.V) (CSE: $CBDT.C) (CSE: $FFNT.C)
Delta, Kelowna, BC –August 20, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site,www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at
Investor Ideas Potcasts, Cannabis News and Stocks on the Move: (CSE: CURA) (CSE: TTT) (TSX: WEED) (NYSE: CGC) (TSXV: KHRN) (CSE: CBDT) (CSE: FFNT)
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
Curaleaf Holdings Inc. (CSE: CURA) (OTC: CURLF) launched its initiative with the Veterans Cannabis Project (VCP), an organization that advocates for legal and supported access of medical cannabis for veterans through the Department of Veterans Affairs, in Oregon.
Customers can now purchase a custom-designed Veterans Cannabis Project pre-roll product, with a portion of all proceeds benefiting the VCP. Each box includes five pre-rolls (total of 2.5 grams) of UKU flower – one of Oregon's top selling flower brands* – and will be available for $13. Images can be downloadedhere.
"Raising awareness of veterans' access to cannabis is an important issue for Curaleaf," said Tim Fitzpatrick, President of Curaleaf Oregon. "Curaleaf can play an important role by educating veterans and consumers on how cannabis may be of great benefit for veterans. We are proud to be able to support our veterans as they look to improve their quality of life."
"As a veteran myself, I was grateful to be made aware of how medical cannabis can help me," said Doug Distaso, VCP's Executive Director. "There are millions of veterans, but federal law makes it illegal for Veteran Health Administration physicians to recommend cannabis as a treatment. This is something we are looking to change. Our partnership with Curaleaf will help veterans gain legal access to cannabis."
Curaleaf officially launched the Veterans Cannabis Project initiative in Maryland earlier this year; products are currently available for purchase in Maryland, Maine and Arizona. The company will continue rolling out the program at Curaleaf dispensaries across the United States. The Veterans Cannabis Project product will also be available for purchase at other cannabis operators later this year.
TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF), creator of the first fully-integrated blockchain platform that registers and tracks intellectual property for the cannabis industry, today announced that it has signed a letter of intent to establish a strategic working relationship with Anandia Laboratories Inc. The two companies intend to collaborate on an integrated testing solution in relation to TruTrace's development of a blockchain-secured traceability ecosystem for the cannabis industry.
Anandia is considered an industry leader in science, genetics, and independent cannabis product testing. Pursuant to the LOI, Anandia will serve as a primary analytical and genetic testing partner in the TruTrace ecosystem. The parties will also explore ways to work together on rapidly expediting and optimizing the testing processes under the Cannabis Act (Canada) as set forth by Health Canada, as well as evolving genetic testing practices in the cannabis industry.
Anandia is also expected to be one of the featured testing facilities in the Shoppers Drug Mart and TruTrace Technologies medical cannabis verification pilot program. As announced by Shoppers at the second annual World Cannabis Congress, the Pilot Program is built on TruTrace's proprietary StrainSecure™ platform, which focuses on testing and verification to confirm the origin, authenticity and quality assurance of cannabis products.
"We are very excited to have Anandia join us as a testing partner in the StrainSecure ecosystem," said TruTrace Technologies CEO Robert Galarza. "Its genetic testing expertise and capabilities combined with its full range of analytical testing makes it a 'one-stop shop' that we expect will play an important role in our traceability program."
"Establishing a comprehensive traceability program is an important step for the cannabis industry in offering full transparency and verification for patients and consumers," said Dr. John Coleman, Anandia President and Co-Founder. "We are supportive of these objectives and look forward to working with TruTrace, Shoppers and others in the Pilot Program."
Under the StrainSecure program, the TruTrace team collects plant testing data and performs genomic verification in plant batches which are then registered in a blockchain-enabled database for intellectual property protection and strain validation. All information gathered from the plants, including their molecular and chemical makeup, can be tracked via the program.
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) announced that it has received a licence from Health Canada for itsKeyLeaf Life Sciencesfacility in Saskatoon, Saskatchewan. Including the Smiths Falls site and the recently licensed BC Tweed extraction site, Canopy Growth now operates three significant extraction assets to support the throughput required for large scale value-add product development.
Canopy Growth recently retrofitted the now fully licensed KeyLeaf facility in Saskatchewan, a company with over 50 years of experience in the extraction industry. This facility is expected to be online in the Fall of 2019 and has the capacity to extract up to 5,000 kilograms of hemp or cannabis biomass per day. The application for the licence was submitted under KeyLeaf's previous name, POS Management Corp. and will be updated in due course. The newly-licensed extraction platform is located in close proximity to Canopy Growth's large-scale outdoor hemp and cannabis grow operations. The Company looks forward to the additional capacity increasing production efficiency, augmenting output volume, and ultimately reducing operational costs for value-add products set to be rolled out in the Canadian recreational and medical markets at the end of calendar year 2019.
"With this milestone, we are executing against the vision of making strategic investments today in order to deliver results over the long term," said Mark Zekulin, CEO, Canopy Growth. "This licence will ensure we have the supply of extraction inputs for the medical, CBD, and recreational markets, especially the next generation of value-add, high margin cannabis products here in Canada."
The KeyLeaf facility, and broader extraction infrastructure that has been recently licensed, will complement the Company's indoor, greenhouse, and outdoor cannabis and hemp growing operations on the one side, and its value-add beverages, vapes, softgels and edibles infrastructure on the other side. The licensing of these facilities brings the Company one major step closer to completing its Canadian build-out, and also represents a blueprint model for international expansion as global market demand dictates.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced today that its shares have received Depository Trust Company full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.
DTC is a subsidiary of the Depository Trust & Clearing Corp., a U.S. company that manages the electronic clearing and settlement of publicly traded companies. DTC eligibility permits shares of Khiron to be distributed, settled and serviced through DTC's automated processes, leveraging the efficiencies created through the electronic clearing and settlement of securities. DTC services provide cost benefits for investors and brokers trading Canadian securities in the United States.
EMPOWER CLINICS INC. (CSE: CBDT) (OTC: EPWCF) today announced that its common shares began trading on the OTCQB Venture Market at the opening of the market, today on August 20th, 2019 under the stock symbol (OTC: EPWCF).
Empower Clinics Inc. (OTCQB: EPWCF) now trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company onOTC Markets | Official site of OTCQX, OTCQB and Pink Markets.
In addition, Empower's shares will continue to be listed on the Canadian Securities Exchange (CSE) under the ticker symbol "CBDT," as well as on the Frankfurt Stock Exchange under the ticker symbol "8EC."
"Our listing on the OTCQB Venture Market in the United States complements Empower's listings on the Canadian and Frankfurt Stock Exchanges, respectively, broadening our investment base as we accelerate our growth strategy in the global medical cannabis and wellness sectors," said Steven McAuley, Empower CEO. "This is a timely milestone, as we have a robust pipeline of activity tied to product development, business development, M&A and, overall company expansion."
4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) announced that it began trading on the OTC Market Group's OTCQX® Best Market under the new ticker symbol "FFNTF" at market open, today on August 20, 2019.
4Front is a cannabis company designed for long-term success and built upon battle-tested operating capabilities, experienced and aligned leadership, a strategic asset base, and a commitment to being a magnet for talent. From plant genetics to the cannabis retail experience, 4Front's team can apply expertise across the value chain. 4Front has invested heavily to assemble a comprehensive collection of management skills and hands-on operating expertise to capitalize on the unique growth opportunity being afforded by the increased legalization of cannabis. For more information,visit 4Front's website.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit:Investorideas.com Investing and trading ideas Podcasts about bitcoin, blockchain, biotech, cannabis, cleantech, sports, mining, tech, support and resistance trading, now on iTunes, Spotify, Google Play Music, iHeart.com, Spreaker, SoundCloud.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles ,podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the dailyCrypto Corner and Podcast,Play by Play sports and stock news column,Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and theAI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: InvestorIdeas - Disclaimer, full disclosure, compensation disclosure Learn more about publishing your news release and our other news services on the Investorideas.com newswire Investorideas.com Newswire press release service-, ticker tag service, podcast news service, Submit stock and business news - be seen on Google News, Apple news, Marketwatch, Financial Content , social media and global RSS syndication and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
Additional disclosure: Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: www.investorideas.com/... Learn more about publishing your news release and our other news services on the Investorideas.com newswire www.investorideas.com/... and tickertagstocknews.com